Foxp3-mediated immunity of human pancreatic cancer cell line PANC-1

American Journal of Immunology

Volumn 5, Issue 4, 2009, Pages 101-107

  Wang, Renxi ^a   Han, Gencheng ^a   Wang, Jianan ^a   Chen, Guojiang ^a   Xu, Ruonan ^a   Wang, Liyan ^a   Li, Xia ^b   Shen, Beifen ^a   Li, Yan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HENAN UNIVERSITY   (China)

Author keywords

Foxp3; Nod mice; PANC 1; Response; Tolerance

Indexed keywords

GAMMA INTERFERON; GLUCOSE; GLUTAMATE DECARBOXYLASE 65; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN PANC 1; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SPLEEN LYMPHOCYTE; TUMOR IMMUNITY;

EID: 75649112664     PISSN: 1553619X     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajisp.2009.101.107     Document Type: Article

References (25)

1. Hori, S., T. Nomura and S. Sakaguchi, 2003. Control of regulatory T cell development by the transcription factor Foxp 3. Sci., 299: 1057-1061. http://www.ncbi.nlm.nih.gov/pubmed/12522256
2. Ramsdell, F. and S.F. Ziegler, 2003. Transcription factors in autoimmunity. Curr. Opin. Immunol., 15: 718-724. http://www.ncbi.nlm.nih.gov/ pubmed/14630208
3. Fontenot, J.D., M.A. Gavin and A.Y. Rudensky, 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol., 4: 330-336. http://www.ncbi.nlm.nih.gov/pubmed/12612578
4. Yagi, H., T. Nomura, K. Nakamura, S. Yamazaki and T. Kitawaki et al., 2004. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol., 16: 1643-1656. PMID: 15466453
5. Allan S.E., L. Passerini, R. Bacchetta, N. Crellin and M. Dai et al., 2005. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest., 115: 3276-3284. PMID: 16211090
6. Wu, Y., M. Borde, V. Heissmeyer, M. Feuerer and A.D. Lapan et al., 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell, 126: 375-387. PMID: 16873067
7. Hinz, S., L. Pagerols-Raluy, H.H. Oberg, O. Ammerpohl and S. Grüssel et al., 2007. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res., 67: 8344-8350. http://cancerres.aacrjournals.org/cgi/content/abstrac t/67/17/8344
8. Ebert, L.M, B.S. Tan, J. Browning, S. Svobodova and S.E. Russell et al., 2008. The regulatory T cell-associated transcription factor foxp3 is expressed by tumor cells. Cancer Res., 68: 3001-3009. http://www.ncbi.nlm.nih. gov/pubmed/18413770
9. Karanikas, V., M. Speletas, M. Zamanakou, F. Kalala and G. Loules et al., 2008. Foxp3 expression in human cancer cells. J. Trans. Med., 6: 19. PMID: PMC2386447/
10. Zuo, T., L. Wang, C. Morrison, X. Chang and H. Zhang et al., 2007. Foxp3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell, 129: 1275-1286. http://www.ncbi.nlm.nih.gov/ pubmed/17570480
11. Monti, P., F. Marchesi, M. Reni, A. Mercalli, V. Sordi et al., 2004. A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile. Virchows Archl., 445: 236-247. http://cat.inist.fr/? aModele=afficheN&cpsidt=16092244
12. Rabinovich, G.A, D. Gabrilovich and E.M. Sotomayor, 2007. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol., 25: 267-296. PMID: 17134371
13. Waldmann, T.A., 2006. Effective cancer therapy through immunomodulation. Annu. Rev. Med., 57: 65-81. PMID: 16409137
14. Li, M.O., Y.Y. Wan, S. Sanjabi, A.K. Robertson and R.A. Flavell, 2006. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol., 24: 99-146. http://www.ncbi.nlm.nih.gov/pubmed/16551245
15. Huber, S., C. Schramm, H.A. Lehr, A. Mann and S. Schmitt et al., 2004. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J. Immunol., 173: 6526-6531. http://www.ncbi.nlm.nih.gov/pubmed/15557141
16. Chen, W., W. Jin, N. Hardegen, K.J. Lei and L. Li et al., 2003. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med., 198: 1875-1886. PMID: 14676299
17. Anderson, M.S. and J.A. Bluestone, 2005. The NOD mouse: A model of immune dysregulation. Annu. Rev. Immunol., 23: 447-485.
18. Lieberman, S.M. and T.P. DiLorenzo, 2003. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens, 62: 359-377. PMID: 15771578
19. Schubert, L.A., E. Jeffery, Y. Zhang, F. Ramsdell and S.F. Ziegler, 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem., 276: 37672-37679. http://www.ncbi.nlm.nih.gov/ pubmed/11483607
20. Mucida, D., N. Kutchukhidze, A. Erazo, M. Russo, J.J. Lafaille and M.A. Curotto de Lafaille, 2005. Oral tolertance in the absence of naturally occurring Tregs. J. Clin. Invest., 115: 1923-1933. http://cat.inist.fr/?aModele= afficheN&cpsidt=1701 7445
21. Hill, N. and N. Sarvetnick, 2002. Cytokines: Promoters and dampeners of autoimmunity. Curr. Opin. Immunol., 14: 791-797. PMID: 12413531
22. Roncarolo, M.G., R. Bacchetta, C. Bordignon, S. Narula and M.K. Levings, 2001. Type 1 T regulatory cells. Immunol. Rev., 182: 68-79. PMID: 11722624
23. Weiner, H.L., 2001. Induction and mechanism of action of transforming growth factor-b secreting Th3 regulatory cells. Immunol. Rev., 182: 207-214. http://www.ncbi.nlm.nih.gov/pubmed/11722636
24. + regulatory T cells and TGF-beta? Gene Ther., 11: 1487-1496. http://cat.inist.fr/?aModele=afficheN&cpsidt=16147527
25. Han, G., Y. Li, J. Wang, R. Wang and G. Chen et al., 2005. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD (500-585). J. Immunol., 174: 4516-4524. http://www.jimmunol.org/ cgi/content/abstract/174/ 8/4516